Ordering Recommendation

HIV-1 combined phenotyping provides antiretroviral susceptibility information for protease inhibitors (PI) and reverse transcriptase inhibitors (NRTI, NNRTI). Intended for patients with documented HIV-1 infection with viral load greater than 500 copies/mL.

Mnemonic
HIV PHENO
Methodology

Polymerase chain reaction (PCR) amplification and viral culture

Performed

Varies

Reported

19-26 days

New York DOH Approval Status
This test is New York DOH approved.
Specimen Required
Patient Preparation
Collect

Lavender (K2 EDTA) or Plasma Preparation Tube (PPT).

Specimen Preparation

Separate from cells within 6 hours of collection. Transfer 3 mL plasma to an ARUP Standard Transport Tube and freeze immediately. (Min: 3 mL)

Storage/Transport Temperature

CRITICAL FROZEN. Separate specimens must be submitted when multiple tests are ordered.

Unacceptable Conditions

Thawed specimens.

Remarks
Stability

Ambient: 6 hours; Refrigerated: 24 hours; Frozen: 2 weeks

Reference Interval

By report

Interpretive Data



Compliance Category

Performed by non-ARUP Laboratory

Note
Hotline History
N/A
CPT Codes

87903; 87904 x11

Components
Component Test Code* Component Chart Name LOINC
3000883 EER HIV-1 PhenoSense 45182-3
3000884 HIV-1 PhenoSense 49665-3
3000885 HIV-1 PhenoSense Interpretation 48767-8
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
  • HIV resistance testing
  • Human Immunodeficiency Virus (HIV) Phenotype Comprehensive
Human Immunodeficiency Virus Type 1 (HIV-1) PhenoSense

Monogram Biosciences